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This is an important, well-written report from an active venous
center with early experience of percutaneous stenting of the il-
iofemoral venous outflow tract. The study shows a high technical
success rate of stent placement: thrombotic occlusion in 5%; cu-
mulative primary and secondary patency rates of 73% and 90%,
respectively, at 36 months; an in-stent restenosis (50%) rate of
13%; and a substantial clinical improvement of the patients. These
numbers are amazingly close to our group’s experience.
The article confirms that endovenous stenting is presently the
method of choice in the treatment of iliocaval outflow obstruction.
Even occlusion canmore often than not be successfully recanalized
and stented. Improved outflow ameliorates the patient’s symptoms
regardless of associated reflux, and, if present, the reflux does not
deteriorate after stent placement. Venous stenting may be consid-
ered a primary intervention in all limbs with chronic disease,
including iliocaval obstruction. In the presence of great saphenous
vein reflux, we have successfully combined the stenting with per-
cutaneous great saphenous vein ablation with or withoutminiphle-
bectomies, thus maintaining the minimally invasive nature of the
procedure.
It is interesting to note that the problems the authors encoun-endovenous stenting procedure; they resulted in technical modifi-
cations. The procedure is better performed with the patient under
full anesthesia, because the recanalization procedure can be time
consuming and the angioplasty is usually painful. Angioplasty
alone is insufficient, and all obstructions should be stented. It is
important to cover the entire lesion with the stent. Oblique veno-
graphic projections were used in this study to identify the extent of
the stenosis, but even multiplane venographies are inferior to
intravascular ultrasonography, which, in my opinion, is vital for
appropriate stent placement. Complete stenting of the lesion pre-
vents early occlusion of the stent and distal restenosis or angling. It
is only with too short a braided stent, which is inadequate to cover
the stenosis, that proximal migration occurs. It is safer and of no
disadvantage to overstent rather than understent a lesion.
On the basis of duplex Doppler findings, this study considered
greater than 50% stenosis with collateral formation significant. This
is an arbitrarily chosen number based on morphologic investiga-
tions, as in other studies. In fact, it is not known at what degree a
venous stenosis is hemodynamically significant, and, thus, no
reliable hemodynamic test exists. Not until such a test has been
found can borderline obstruction be diagnosed accurately and
patients correctly selected for stenting.
